Perfusion-induced systemic hyperthermia for the treatment of advanced lung cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812Status:Topic selectionProgramme:Health technology evaluationExpected publication date: TBC
Archimedes for biopsy of suspected lung cancerStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Signatera molecular residual disease assay (MT741)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)Status:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC
Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations [TSID12011]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC